Cargando…

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

Cardiovascular disease is the leading cause of death in women and men globally, with most due to atherosclerotic cardiovascular disease (ASCVD). Despite progress during the last 30 years, ASCVD mortality is now increasing, with the fastest relative increase in middle-aged women. Missed or delayed di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roeters van Lennep, Jeanine E, Tokgözoğlu, Lale S, Badimon, Lina, Dumanski, Sandra M, Gulati, Martha, Hess, Connie N, Holven, Kirsten B, Kavousi, Maryam, Kayıkçıoğlu, Meral, Lutgens, Esther, Michos, Erin D, Prescott, Eva, Stock, Jane K, Tybjaerg-Hansen, Anne, Wermer, Marieke J H, Benn, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576616/ https://www.ncbi.nlm.nih.gov/pubmed/37611089 http://dx.doi.org/10.1093/eurheartj/ehad472

Ejemplares similares

Current Treatment Options in Homozygous Familial Hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2022)

Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
por: Al Dubayee, Mohammed, et al.
Publicado: (2022)

Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative
por: Kavousi, Maryam, et al.
Publicado: (2023)

The landscape of preventive cardiology in Turkey: Challenges and successes
por: Tokgozoglu, Lale, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic in patients with a previous history of premature myocardial infarction
por: Kayikcioglu, Meral, et al.
Publicado: (2020)

Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2020)

Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2021)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Aging, Cardiovascular Risk, and SHBG Levels in Men and Women From the General Population
por: Aribas, Elif, et al.
Publicado: (2021)

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
por: Cuchel, Marina, et al.
Publicado: (2023)

Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
por: Benschop, Laura, et al.
Publicado: (2019)

Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
por: Troensegaard, Hannibal, et al.
Publicado: (2023)

Efficacy and Safety of High Potent P2Y(12) Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex‐Specific Systematic Review and Meta‐Analysis
por: Schreuder, Michelle M., et al.
Publicado: (2020)

Sex steroids and sex steroid‐binding globulin levels amongst middle‐aged and elderly men and women from general population
por: Aribas, Elif, et al.
Publicado: (2022)

Association Between Sex-Specific Risk Factors and Risk of New-Onset Atrial Fibrillation Among Women
por: Lu, Zuolin, et al.
Publicado: (2022)

The spoils of war and the long-term spoiling of health conditions of entire nations
por: Navarese, Eliano P., et al.
Publicado: (2022)

Prevalence of microvascular angina among patients with stable symptoms in the absence of obstructive coronary artery disease: a systematic review
por: Aribas, Elif, et al.
Publicado: (2021)

Reflections from ACC 2015
por: Tokgözoğlu, Lale
Publicado: (2015)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

Claims-based Frailty indices may function as long-term risk estimates for elderly patients after hospitalization
por: Kayikcioglu, Meral
Publicado: (2021)

Highlights form ESC 2015
por: Tokgözoğlu, Prof. Lale
Publicado: (2015)

A Woman’s Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations
por: Kazzi, Brigitte, et al.
Publicado: (2023)

Maternal lipid levels in early pregnancy as a predictor of childhood lipid levels: a prospective cohort study
por: Adank, Maria C., et al.
Publicado: (2022)

Catamenial chest pain and spontaneous coronary artery dissection: A case report
por: Al Fatly, Zainab, et al.
Publicado: (2020)

Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
por: Benschop, Laura, et al.
Publicado: (2019)

Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation
por: Sleutjes, Jasmijn A M, et al.
Publicado: (2022)

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
por: Ginsberg, Henry N, et al.
Publicado: (2021)

Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
por: Nordestgaard, Liv Tybjærg, et al.
Publicado: (2022)

The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
por: Schreuder, Michelle M., et al.
Publicado: (2021)

Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
por: Ambrož, Martina, et al.
Publicado: (2021)

Highlights from ACC 15 Scientific Sessions: Part 1
por: Kaymaz, Cihangir, et al.
Publicado: (2015)

Highlights from ACC 15 Scientific Sessions: Part 2
por: Kaymaz, Cihangir, et al.
Publicado: (2015)

What do the “new” Pulmonary Hypertension Guidelines tell us: should we change our practice?
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Comparison of Current International Guidelines for the Management of Dyslipidemia
por: Aygun, Sevda, et al.
Publicado: (2022)

Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions
por: van den Wijngaard, Ido R., et al.
Publicado: (2016)

Questionnaire survey on cardiologists’ view and management of coronary microvascular disease in clinical practice
por: Aribas, E., et al.
Publicado: (2019)

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
por: Ramaswami, Uma, et al.
Publicado: (2020)

Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when
por: Groenhof, T Katrien J, et al.
Publicado: (2017)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nqkm7q0e385b05jes37pi1asam